Sector consensus Dianthus Therapeutics, Inc.
Equities
DNTH
US2528281080
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.62 USD | -4.86% | -7.67% | +155.96% |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
50.33 | +80.73% | 9 | |||||||
1,155.01 | +0.89% | 25 | |||||||
509.82 | +8.22% | 29 | |||||||
510.75 | +2.38% | 15 | |||||||
99.07 | +8.81% | 18 | |||||||
272.96 | +41.20% | 21 | |||||||
2,409.94 | +29.95% | 17 | |||||||
58.36 | +48.08% | 18 | |||||||
145.00 | +25.78% | 7 | |||||||
193.59 | +51.61% | 20 | |||||||
87.50 | +21.83% | 16 | |||||||
168.72 | +39.85% | 25 | |||||||
18.79 | +28.29% | 3 | |||||||
82.93 | +64.68% | 19 | |||||||
1,015.14 | +18.32% | 7 | |||||||
59.10 | -0.24% | 10 | |||||||
27.52 | +7.89% | 21 | |||||||
856.00 | +25.33% | 4 | |||||||
164.73 | +56.54% | 13 | |||||||
Average | 415.01 | +29.48% | 16 | ||||||
Weighted average by Cap. | 636.45 | +15.18% | 21 |
- Stock Market
- Equities
- DNTH Stock
- Sector Dianthus Therapeutics, Inc.
- Sector consensus